drugset / Trial / NCT00558961
Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine maximum tolerated dose of Gleevec in combination with Chlorambucil in previously treated CLL patients.
Timeline
- Start
- 2005-10
- Primary completion
- 2009-04
- Completion
- 2009-04
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | 300 mg | — |
| Subject | Imatinib | Small molecule | 400 mg | — |
| Subject | Imatinib | Small molecule | 600 mg | — |
| Background | Chlorambucil | Other / unclassified | 8 mg/m2 | — |